Latest Breaking News On - Quarter for paratek pharmaceuticals - Page 1 : comparemela.com

Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) Position Reduced by Perkins Capital Management Inc

Perkins Capital Management Inc. lowered its position in shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Free Report) by 70.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,700 shares of the specialty pharmaceutical company’s stock after selling 32,000 shares during the quarter. Perkins […]

Michael bighamRandallb brennerRenaissance technologiesNews ratings for paratek pharmaceuticals dailyJefferies financial groupParatek pharmaceuticals company profileSecurities exchange commissionParatek pharmaceuticals incTopco ltdPerkins capital management incParatek pharmaceuticals stockParatek pharmaceuticalsVanguard group incJpmorgan chase coQuarter for paratek pharmaceuticalsCharles schwab investment management inc

Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) General Counsel William M Haskel Sells 34,526 Shares of Stock

Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) General Counsel William M Haskel Sells 34,526 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Williamm haskelParatek pharmaceuticals incQuarter for paratek pharmaceuticalsParatek pharmaceuticalsCm managementDeltec asset managementJefferies financial groupNews ratings for paratek pharmaceuticals dailyArete wealth advisorsParatek pharmaceuticals tradingInstitutional trading of paratek pharmaceuticalsSecurities exchange commissionCutter co brokerage incGet free reportGeneral counsel williamExchange commission

Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) Chairman Michael Bigham Sells 31,250 Shares

Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) Chairman Michael Bigham Sells 31,250 Shares
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Michael bighamParatek pharmaceuticals incCi private wealthQuarter for paratek pharmaceuticalsParatek pharmaceuticalsInstitutional investors weigh in on paratek pharmaceuticalsJefferies financial groupParatek pharmaceuticals price performanceCutter co brokerage incNews ratings for paratek pharmaceuticals dailyCommonwealth equity servicesGet free reportChairman michael bighamEquity servicesExoduspoint capital managementFinancial group

Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) Insider Randall B Brenner Sells 27,603 Shares

Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) Insider Randall B Brenner Sells 27,603 Shares
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesRandallb brennerQuarter for paratek pharmaceuticalsParatek pharmaceuticalsVanguard group incBlackrock incCapital managementParatek pharmaceuticals incNews ratings for paratek pharmaceuticals dailyParatek pharmaceuticals tradingJefferies financial groupCarlyle group incInstitutional investors weigh in on paratek pharmaceuticalsParatek pharmaceuticals company profileAmerican investors coGet free report

General American Investors Co Inc Raises Stock Holdings in Paratek Pharmaceuticals, Inc (NASDAQ:PRTK)

General American Investors Co Inc Raises Stock Holdings in Paratek Pharmaceuticals, Inc (NASDAQ:PRTK)
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesParatek pharmaceuticals stock performanceGeneral american investors coQuarter for paratek pharmaceuticalsArete wealth advisorsParatek pharmaceuticals incAmerican investors coManagers groupJefferies financial groupVirtu financialParatek pharmaceuticalsParatek pharmaceuticals profileNews ratings for paratek pharmaceuticals dailyGeneral american investorsFree reportAmerican investors